These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31075522)

  • 21. Chronology of comorbid and principal syndromes in first-episode psychosis.
    Strakowski SM; Keck PE; McElroy SL; Lonczak HS; West SA
    Compr Psychiatry; 1995; 36(2):106-12. PubMed ID: 7758295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
    Corcoran CM; Kimhy D; Stanford A; Khan S; Walsh J; Thompson J; Schobel S; Harkavy-Friedman J; Goetz R; Colibazzi T; Cressman V; Malaspina D
    Schizophr Res; 2008 Dec; 106(2-3):286-93. PubMed ID: 18809298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence.
    Knowles EEM; Mathias SR; Pearlson GD; Barrett J; Mollon J; Denbow D; Aberzik K; Zatony M; Glahn DC
    Schizophr Res; 2019 Apr; 206():333-346. PubMed ID: 30482645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suicidality before and in the early phases of first episode psychosis.
    Barrett EA; Sundet K; Faerden A; Nesvåg R; Agartz I; Fosse R; Mork E; Steen NE; Andreassen OA; Melle I
    Schizophr Res; 2010 Jun; 119(1-3):11-7. PubMed ID: 20399077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.
    Katz G; Kunyvsky Y; Hornik-Lurie T; Raskin S; Abramowitz MZ
    Isr J Psychiatry Relat Sci; 2016; 53(3):10-15. PubMed ID: 28492376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychiatric comorbidity in individuals at-risk for psychosis: Relationships with symptoms, cognition and psychosocial functioning.
    Chang WC; Ng CM; Chan KN; Lee HC; Chan SI; Chiu SS; Lee HM; Chan KW; Wong MC; Chan KL; Yeung WS; Chan CWH; Choy LW; Chong SY; Siu MW; Lo TL; Yan WC; Ng MK; Poon LT; Pang PF; Lam WC; Wong YC; Chung WS; Mo YM; Lui SY; Hui LM; Chen EYH
    Early Interv Psychiatry; 2021 Jun; 15(3):616-623. PubMed ID: 32441490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of psychotic and non-psychotic disorders in relatives of patients with a first episode psychosis.
    Faridi K; Pawliuk N; King S; Joober R; Malla AK
    Schizophr Res; 2009 Oct; 114(1-3):57-63. PubMed ID: 19666214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the pattern of substance abuse after the onset of psychosis.
    Kaiser R; Löhrer F; Morgan V; Hambrecht M
    Aust N Z J Psychiatry; 2005 Jun; 39(6):467-72. PubMed ID: 15943648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s.
    Donoghue K; Medley I; Brewin J; Glazebrook C; Mason P; Cantwell R; Jones PB; Harrison G; Doody GA
    Soc Psychiatry Psychiatr Epidemiol; 2011 Feb; 46(2):137-42. PubMed ID: 20043146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use.
    Ruiz-Veguilla M; Gurpegui M; Barrigón ML; Ferrín M; Marín E; Rubio JL; Gutiérrez B; Pintor A; Cervilla J
    Schizophr Res; 2009 Feb; 107(2-3):158-64. PubMed ID: 18805673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prevalence of comorbid anxiety in schizophrenia, schizoaffective disorder and bipolar disorder.
    Cosoff SJ; Hafner RJ
    Aust N Z J Psychiatry; 1998 Feb; 32(1):67-72. PubMed ID: 9565185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender differences in first-episode psychosis at 5-year follow-up--two different courses of disease? Results from the OPUS study at 5-year follow-up.
    Thorup A; Albert N; Bertelsen M; Petersen L; Jeppesen P; Le Quack P; Krarup G; Jørgensen P; Nordentoft M
    Eur Psychiatry; 2014 Jan; 29(1):44-51. PubMed ID: 23394824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substance abuse in first-episode non-affective psychosis.
    Larsen TK; Melle I; Auestad B; Friis S; Haahr U; Johannessen JO; Opjordsmoen S; Rund BR; Simonsen E; Vaglum P; McGlashan TH
    Schizophr Res; 2006 Dec; 88(1-3):55-62. PubMed ID: 16971092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The EUropean Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI): Incidence and First-Episode Case-Control Programme.
    Gayer-Anderson C; Jongsma HE; Di Forti M; Quattrone D; Velthorst E; de Haan L; Selten JP; Szöke A; Llorca PM; Tortelli A; Arango C; Bobes J; Bernardo M; Sanjuán J; Santos JL; Arrojo M; Parellada M; Tarricone I; Berardi D; Ruggeri M; Lasalvia A; Ferraro L; La Cascia C; La Barbera D; Menezes PR; Del-Ben CM; ; Rutten BP; van Os J; Jones PB; Murray RM; Kirkbride JB; Morgan C
    Soc Psychiatry Psychiatr Epidemiol; 2020 May; 55(5):645-657. PubMed ID: 31974809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients.
    Rabinowitz J; Bromet EJ; Lavelle J; Carlson G; Kovasznay B; Schwartz JE
    Psychol Med; 1998 Nov; 28(6):1411-9. PubMed ID: 9854282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.
    Miller TJ; Zipursky RB; Perkins D; Addington J; Woods SW; Hawkins KA; Hoffman R; Preda A; Epstein I; Addington D; Lindborg S; Marquez E; Tohen M; Breier A; McGlashan TH
    Schizophr Res; 2003 May; 61(1):19-30. PubMed ID: 12648732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.
    Mané A; Fernández-Expósito M; Bergé D; Gómez-Pérez L; Sabaté A; Toll A; Diaz L; Diez-Aja C; Perez V
    Psychiatry Res; 2015 Sep; 229(1-2):70-4. PubMed ID: 26235479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
    Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; Samet S; Schanzer B
    Schizophr Bull; 2006 Oct; 32(4):618-25. PubMed ID: 16873441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in first episode psychosis.
    Køster A; Lajer M; Lindhardt A; Rosenbaum B
    Soc Psychiatry Psychiatr Epidemiol; 2008 Dec; 43(12):940-6. PubMed ID: 18574541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between psychopathology of first-episode psychosis patients within the schizophrenia spectrum and previous offending.
    Munkner R; Haastrup S; Joergensen T; Kramp P
    Nord J Psychiatry; 2009; 63(2):124-31. PubMed ID: 19023698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.